Clinical trial
Using Genetics and Shared Decision Making to Improve Lung Cancer Care: A Developmental Study
NCT03944265 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Using Genetics and Shared Decision Making to Improve Lung Cancer Care: A Developmental Study
- Lead sponsor
- Thomas Jefferson University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 8, 2019
- Completion date
- December 31, 2020
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
activating alk gene mutation negative, activating egfr gene mutation negative, activating ros1 gene mutation negative, health care provider, lung non-small cell carcinoma, stage iv lung cancer ajcc v8, stage iva lung cancer ajcc v8, stage ivb lung cancer ajcc v8